X-138754725-C-A

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The NM_001139500.2(FGF13):​c.218-45797G>T variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.368 in 110,148 control chromosomes in the GnomAD database, including 6,372 homozygotes. There are 11,545 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.37 ( 6372 hom., 11545 hem., cov: 22)

Consequence

FGF13
NM_001139500.2 intron

Scores

2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: 0.258

Publications

7 publications found
Variant links:
Genes affected
FGF13 (HGNC:3670): (fibroblast growth factor 13) The protein encoded by this gene is a member of the fibroblast growth factor (FGF) family. FGF family members possess broad mitogenic and cell survival activities, and are involved in a variety of biological processes, including embryonic development, cell growth, morphogenesis, tissue repair, tumor growth, and invasion. This gene is located in a region on chromosome X, which is associated with Borjeson-Forssman-Lehmann syndrome (BFLS), making it a possible candidate gene for familial cases of the BFLS, and for other syndromal and nonspecific forms of X-linked cognitive disability mapping to this region. Alternative splicing of this gene at the 5' end results in several transcript variants encoding different isoforms with different N-termini. [provided by RefSeq, Nov 2008]
FGF13 Gene-Disease associations (from GenCC):
  • developmental and epileptic encephalopathy, 90
    Inheritance: XL Classification: STRONG, MODERATE, LIMITED Submitted by: G2P, Labcorp Genetics (formerly Invitae), Ambry Genetics
  • undetermined early-onset epileptic encephalopathy
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.99).
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.58 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_001139500.2. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
FGF13
NM_001139500.2
c.218-45797G>T
intron
N/ANP_001132972.1Q92913-3
FGF13
NM_001139501.2
c.131-45797G>T
intron
N/ANP_001132973.1Q92913-5
FGF13
NM_001139502.2
c.131-45797G>T
intron
N/ANP_001132974.1Q92913-5

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
FGF13
ENST00000436198.6
TSL:2
c.218-45797G>T
intron
N/AENSP00000396198.2Q92913-3
FGF13
ENST00000441825.8
TSL:5
c.131-45797G>T
intron
N/AENSP00000409276.2Q92913-5
FGF13
ENST00000455663.5
TSL:3
c.236-45797G>T
intron
N/AENSP00000406916.1B1AJW0

Frequencies

GnomAD3 genomes
AF:
0.368
AC:
40534
AN:
110093
Hom.:
6367
Cov.:
22
show subpopulations
Gnomad AFR
AF:
0.587
Gnomad AMI
AF:
0.396
Gnomad AMR
AF:
0.304
Gnomad ASJ
AF:
0.240
Gnomad EAS
AF:
0.551
Gnomad SAS
AF:
0.356
Gnomad FIN
AF:
0.303
Gnomad MID
AF:
0.305
Gnomad NFE
AF:
0.259
Gnomad OTH
AF:
0.332
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.368
AC:
40585
AN:
110148
Hom.:
6372
Cov.:
22
AF XY:
0.356
AC XY:
11545
AN XY:
32462
show subpopulations
African (AFR)
AF:
0.587
AC:
17728
AN:
30210
American (AMR)
AF:
0.305
AC:
3145
AN:
10314
Ashkenazi Jewish (ASJ)
AF:
0.240
AC:
633
AN:
2637
East Asian (EAS)
AF:
0.551
AC:
1897
AN:
3441
South Asian (SAS)
AF:
0.356
AC:
912
AN:
2562
European-Finnish (FIN)
AF:
0.303
AC:
1751
AN:
5772
Middle Eastern (MID)
AF:
0.307
AC:
65
AN:
212
European-Non Finnish (NFE)
AF:
0.259
AC:
13690
AN:
52835
Other (OTH)
AF:
0.334
AC:
500
AN:
1499
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.504
Heterozygous variant carriers
0
870
1740
2609
3479
4349
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
380
760
1140
1520
1900
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.325
Hom.:
2119
Bravo
AF:
0.380

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.99
CADD
Benign
1.1
DANN
Benign
0.40
PhyloP100
0.26
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs591; hg19: chrX-137836887; API
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.